Healthcare -
Biotechnology - NASDAQ - US
$ 7.47
1.41 %
$ 160 M
Market Cap
-1.59
P/E
ENTA - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ENTA - Enanta Pharmaceuticals, Inc.
-27.6 M
LAST VALUE
-54.24%
2 YEAR CAGR
-63.64%
5 YEAR CAGR
-37.83%
10 YEAR CAGR